4//SEC Filing
Allouche Cyril 4
Accession 0001479290-19-000036
CIK 0001479290other
Filed
Mar 18, 8:00 PM ET
Accepted
Mar 19, 8:58 PM ET
Size
6.4 KB
Accession
0001479290-19-000036
Insider Transaction Report
Form 4
Allouche Cyril
Principal Financial Officer
Transactions
- Tax Payment
Common Stock
2019-03-15$15.45/sh−252$3,893→ 6,898 total - Sale
Common Stock
2019-03-18$15.48/sh−498$7,709→ 6,400 total
Footnotes (2)
- [F1]Represents the number of shares withheld by and surrendered to the issuer on March 15, 2019, to satisfy tax withholding obligations that arose in connection with the vesting of a Restricted Stock Award ("RSA") for 2,250 shares. The RSA vests in three equal annual installments from March 15, 2018, subject to Mr. Allouche's Continuous Service (as defined in the Issuer's 2014 Equity Incentive Plan) on each vesting date.
- [F2]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by Mr. Allouche.
Documents
Issuer
Revance Therapeutics, Inc.
CIK 0001479290
Entity typeother
Related Parties
1- filerCIK 0001744573
Filing Metadata
- Form type
- 4
- Filed
- Mar 18, 8:00 PM ET
- Accepted
- Mar 19, 8:58 PM ET
- Size
- 6.4 KB